Medical benefit drug policy list
Effective January 1, 2026, oncology-related medications for Commercial and Medicare Part B may be subject to updated prior authorization requirements. Visit the Evolent website to review the oncology-related medications policies.
Blue Shield Medicare plans follow Medicare guidelines for risk allocation and Medicare national and local coverage guidelines. If there is not a fully established or there is an absence of any applicable Medicare statute, regulation, guideline, Blue Shield Medicare medication policies will be used to determine medical necessity.
View the Blue Shield Medicare Part B medication policies:
Part B drugs may be subject to step therapy. View the Part B Step Therapy criteria:
- Medicare PPO Part B step therapy criteria (PDF, 134 KB)
Medical Benefit drug policies for Commercial plans
- Policy Name
- abaloparatide (Tymlos)
- abatacept (Orencia), intravenous
- abatacept (Orencia), subcutaneous
- abobotulinumtoxinA (Dysport)
- adalimumab (Humira)
- adalimumab-aacf (Idacio)
- adalimumab-aaty (Yuflyma)
- adalimumab-adaz (Hyrimoz)
- adalimumab-adbm (Cyltezo)
- adalimumab-atto (Amjevita)
- adalimumab-afzb (Abrilada)
- adalimumab-aqvh (Yusimry)
- adalimumab-bwwd (Hadlima)
- adalimumab-fkjp (Hulio)
- adalimumab-ryvk (Simlandi)
- ADAMTS13, recombinant-krhn (Adzynma)
- afamelanotide (Scenesse)
- aflibercept (Eylea, Eylea HD)
- aflibercept-ayyh (Pavblu)
- agalsidase beta (Fabrazyme)
- alemtuzumab (Lemtrada)
- alglucosidase alfa (Lumizyme)
- alirocumab (Praluent)
- anakinra (Kineret)
- anifrolumab-fnia (Saphnelo)
- antihemophilic factor, human (Koate)
- antihemophilic factor, human, method m, monoclonal purified (Hemofil M)
- antihemophilic factor, recombinant (Advate)
- antihemophilic factor, recombinant (Kogenate FS)
- antihemophilic factor, recombinant (KOVALTRY)
- antihemophilic factor, recombinant (NovoEight)
- antihemophilic factor, recombinant (NUWIQ)
- antihemophilic factor, recombinant (Xyntha Solofuse)
- antihemophilic factor, recombinant (Xyntha)
- antihemophilic factor, recombinant, Fc fusion protein (ELOCTATE)
- antihemophilic factor, recombinant, Fc-VWF-XTEN fusion protein-ehtl (ALTUVIIIO)
- antihemophilic factor, recombinant, glycopegylated-exei (Esperoct)
- antihemophilic factor, recombinant, PEGylated (ADYNOVATE)
- antihemophilic factor, recombinant, PEGylated-aucl (Jivi)
- antihemophilic factor, recombinant, porcine sequence (OBIZUR)
- antihemophilic factor, recombinant, single chain (AFSTYLA)
- antihemophilic factor/von Willebrand factor complex, human (Alphanate)
- antihemophilic factor/von Willebrand factor complex, human (Humate-P)
- anti-inhibitor coagulant complex (FEIBA)
- Anti-thymocte globulin (Atgam)
- apomorphine (Onapgo)
- apomorphine hydrochloride (Apokyn)
- asfotase alfa (Strensiq)
- asfotase-alfa (Strensiq), office administered
- atidarsagene autotemcel (Lenmeldy)
- avacincaptad pegol (Izervay)
- avalglucosidase alfa-ngpt (Nexviazyme)
- axatilimab-csfr (Niktimvo)
- belatacept (Nulojix)
- belimumab (Benlysta), intravenous
- belimumab (Benlysta), subcutaneous
- benralizumab (Fasenra), autoinjector
- benralizumab (Fasenra), prefilled syringe
- beremagene geperpavec-svdt (Vyjuvek)
- betibeglogene autotemcel (Zynteglo)
- bevacizumab (Alymsys, Avastin, Mvasi, Vegzelma, Zirabev)
- bimatoprost implant (Durysta)
- bremelanotide (Vyleesi)
- brodalumab (Siliq)
- brolucizumab-dbll (Beovu)
- burosumab-twza (Crysvita)
- C1 esterase inhibitor (Berinert)
- C1 esterase inhibitor (Cinryze)
- C1 esterase inhibitor (Haegarda)
- C1 esterase inhibitor (Ruconest)
- canakinumab (Ilaris)
- cantharidin (Ycanth)
- caplacizumab-yhdp (Cablivi), subsequent doses
- capsaicin patch (Qutenza)
- casimersen (Amondys 45)
- cerliponase alfa (Brineura)
- certolizumab pegol (Cimzia), prefilled syringe
- certolizumab pegol (Cimzia), vials
- cipaglucosidase alfa-atga (Pombiliti)
- coagulation factor IX, human (AlphaNine SD)
- coagulation factor IX, recombinant (BeneFIX)
- coagulation factor IX, recombinant (Ixinity)
- coagulation factor IX, recombinant (Recombinate)
- coagulation factor IX, recombinant (RIXUBIS)
- coagulation factor IX, recombinant, albumin fusion protein (Idelvion)
- coagulation factor IX, recombinant, Fc fusion protein (Alprolix)
- coagulation factor IX, recombinant, GlycoPEGylated (Rebinyn)
- coagulation factor VIIa, recombinant (NovoSeven)
- coagulation factor VIIa, recombinant-jncw (SEVENFACT)
- coagulation factor X, human (Coagadex)
- coagulation factor XIII A-subunit, recombinant (Tretten)
- collagenase clostridium histolyticum (Xiaflex)
- concizumab-mtci (Alhemo)
- corticotropin (Acthar)
- corticotropin (Purified Cortropin Gel)
- crizanlizumab-tmca (Adakveo)
- crovalimab-akkz (PiaSky)
- darbepoetin alfa (Aranesp)
- daxibotulinumtoxinA-lanm (Daxxify)
- defibrotide (Defitelio)
- degarelix (Firmagon)
- delandistrogene moxeparvovec-rokl (Elevidys)
- denosumab (Prolia, Bildyos, Conexxence, Jubbonti, Ospomyv, Stoboclo)
- dexamethasone intravitreal implant (Ozurdex)
- donanemab-azbt (Kisunla)
- dupilumab (Dupixent)
- ecallantide (Kalbitor)
- eculizumab (BKEMV, Epysqli, Soliris)
- edaravone (Radicava)
- efgartigimod alfa-fcab (Vyvgart)
- efgartigimod alfa-fcab and hyaluronidase-qvfc (Vyvgart Hytrulo)
- elapegademase-lvlr (Revcovi)
- elivaldogene autotemcel (Skysona)
- elosulfase alfa (Vimizim)
- emapalumab-lzsg (Gamifant)
- emicizumab-kxwh (Hemlibra)
- epoetin alfa (Epogen, Procrit)
- epoetin alfa-eobx (Retacrit)
- epoprostenol (Flolan, Veletri)
- eptinezumab-jjmr (Vyepti)
- erenumab-aoooe (Aimovig)
- esketamine (Spravato)
- etanercept (Enbrel)
- eteplirsen (Exondys 51)
- etranacogene-dezaparvovec (Hemgenix)
- evinacumab-dgnb (Evkeeza)
- evolucumab (Repatha)
- exagamglogene autotemcel (Casgevy)
- factor IX complex (Profilnine SD)
- factor XIII concentrate, human (Corifact)
- faricimab-svoa (Vabysmo)
- fecal microbiota live-jslm (Rebyota)
- ferric carboxymaltose (Injectafer), ferric derisomaltose (Monoferric), and iron dextran (Infed)
- fibrinogen concentrate, human (RiaSTAP)
- fibrinogen, human (Fibryga)
- filgrastim (Neupogen, Nivestym, Nypozi, Releuko, Zarxio)
- fitusiran (Qfitlia)
- fluocinolone acetonide intravitreal implant (Iluvien, Retisert, Yutiq)
- foscarbidopa and foslevodopa (Vyalev)
- fosdenopterin (Nulibry)
- fremanezumab-vfrm (Ajovy)
- galcanezumab-gnlm (Emgality)
- galsulfase (Naglazyme)
- givosiran (Givlaari)
- glatiramer (Copaxone, Glatopa)
- golimumab (Simponi Aria)
- golimumab (Simponi)
- golodirsen (Vyondys 53)
- grass pollens allergen extract (Oralair)
- growth hormone
- guselkumab (Tremfya), intravenous
- guselkumab (Tremfya), subcutaneous
- histrelin implant (Supprelin LA)
- house dust mite allergen extract (Odactra)
- hyaluronan (Hymovis)
- hyaluronan (Monovisc)
- hylan G-F 20 (Synvisc One)
- hylan G-F 20 (Synvisc)
- ibalizumab-uiyk (Trogarzo)
- icatibant (Firazyr, Sajazir)
- idursulfase (Elaprase)
- imiglucerase (Cerezyme)
- immune globulin intravenous (Alyglo, Asceniv, Bivigam, Cytogam, Gammagard liquid, Gammagard S/D, Gammaked, Gammaplex, Gamunex-C, Octagam, Privigen, Panzyga)
- immune globulin subcutaneous (Cutaquig, Cuvitru, Gammagard liquid, Gammaked, Gamunex-C, Hizentra, Hyqvia, Xembify)
- inclisiran (Leqvio)
- incobotulinumtoxinA (Xeomin)
- inebilizumab-cdon (Uplizna)
- infliximab (Avsola, Inflectra, Remicade, Renflexis)
- inotersen (Tegsedi)
- interferon beta-1a (Avonex)
- interferon beta-1b (Betaseron, Extavia)
- interferon gamma-1b (Actimmune)
- isavuconazonium sulfate (Cresemba)
- ixekizumab (Taltz)
- ketamine (Ketalar)
- lanadelumab-flyo (Takhzyro)
- lanreotide (Somatuline)
- laronidase (Aldurazyme)
- lecanemab-irmb (Leqembi)
- lenacapavir (Sunlenca)
- letermovir Injection (Prevymis)
- leuprolide (Camcevi)
- leuprolide acetate (Fensolvi)
- lonapegsomatropin-tcgd (Skytrofa)
- lovotibeglogene autotemcel (Lyfgenia)
- lumasiran (Oxlumo)
- luspatercept-aamt (Reblozyl)
- marstacimab-hncq (Hympavzi)
- mecasermin (Increlex)
- mepolizumab (Nucala), prefilled autoinjector and syringe
- mepolizumab (Nucala), vials
- methotrexate(Otrexup, Rasuvo, RediTrex), subcutaneous
- methoxy polyethylene glycol-epoetin beta (Mircera)
- methylnatrexone (Relistor)
- metreleptin (Myalept)
- miglustat (Opfolda)
- mirikizumab-mrkz (Omvoh), intravenous
- mirikizumab-mrkz (Omvoh), subcutaneous
- natalizumab (Tysabri, Tyruko)
- nedosiran (Rivfloza), prefilled syringe
- nedosiran (Rivfloza), vials
- nemolizumab-ilto (Nemluvio)
- nipocalimab-aahu (Imaavy)
- nusinersen (Spinraza)
- ocrelizumab (Ocrevus)
- ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo)
- Octreotide (Sandostatin) intravenous and Octreotide LAR (Sandostatin LAR)
- octreotide (Sandostatin), subcutaneous
- ofatumumab (Kesimpta)
- olipudase alfa-rpcp (Xenpozyme)
- omacetaxine (Synribo)
- omalizumab (Xolair)
- omidubicel-onlv (Omisirge)
- onabotulinumtoxinA (Botox)
- onasemnogene abeparvovecxioi (Zolgensma)
- palifermin (Kepivance)
- pasireotide (Signifor LAR)
- pasireotide (Signifor)
- patisiran (Onpattro)
- peanut (Arachis hypogaea) Allergen Powder-dnfp (Palforzia)
- pegcetacoplan (Empaveli)
- pegcetacoplan injection (Syfovre)
- Pegfilgrastim (Neulasta, Fulphila, Fylnetra, Nyvepria, Stimufend, Udenyca, Ziextenzo)
- peginterferon beta-1a (Plegridy)
- pegloticase (Krystexxa)
- pegunigalsidase alfa-iwxj (Elfabrio)
- pegvaliase-pqpz (Palynziq)
- pegvisomant (Somavert)
- peramivir (Rapivab)
- plasminogen human-tvmh (Ryplazim)
- plerixafor (Mozobil)
- posaconazole injection (Noxafil)
- pozelimab-bbfg (Veopoz)
- prademagene zamikeracel (Zevaskyn)
- protein C concentrate, human (Ceprotin)
- ranibizumab (Lucentis)
- ranibizumab intravitreal implant (Susvimo)
- ranibizumab-eqrn (Cimerli)
- ranibizumab-nuna (Byooviz)
- ravulizumab-cwvz (Ultomiris)
- remestemcel-L-rknd (Ryoncil)
- reslizumab (Cinqair)
- revakinagene taroretcel-lwey (Encelto)
- rilonacept (Arcalyst)
- rimabotulinumtoxinB (Myobloc)
- risankizumab-rzaa (Skyrizi), intravenous
- risankizumab-rzaa (Skyrizi), subcutaneous
- rituximab (Rituximab,Riabni, Ruxience, Truxima)
- romiplostim (Nplate)
- romosozumab-aqqg (Evenity)
- ropeginterferon alfa-2b-njft (Besremi)
- rozanolixizumab-noli (Rystiggo)
- sargramostim (Leukine)
- sarilumab (Kevzara)
- satralizumabmwge (Enspryng)
- sebelipase alfa (Kanuma)
- secukinumab (Cosentyx), intravenous
- secukinumab (Cosentyx), subcutaneous
- selexipag (Uptravi)
- self-administered drugs
- setmelanotide (Imcivree)
- short ragweed pollen allergen extract (Ragwitek)
- sildenafil (Revatio)
- site of care redirection
- sodium hyaluronate (Durolane)
- sodium hyaluronate (Euflexxa)
- sodium hyaluronate (Gel One)
- sodium hyaluronate (Gelsyn-3)
- sodium hyaluronate (GenVisc 850)
- sodium hyaluronate (Hyalgan)
- sodium hyaluronate (Orthovisc)
- sodium hyaluronate (Supartz FX)
- sodium hyaluronate (Synojoynt)
- sodium hyaluronate (Triluron)
- sodium hyaluronate (TriVisc)
- sodium hyaluronate (Visco-3)
- somatropin (Genotropin, Humatrope, Norditropin, Nutropin, Omnitrope, Saizen, Zorbtive, Zomacton)
- somatropin (Serostim)
- sotatercept-csrk (Winrevair)
- spesolimab-sbzo (Spevigo), 300mg subcutaneous
- spesolimab-sbzo (Spevigo), intravenous and 600 mg subcutaneous
- Sumatriptan (Imitrex, Zembrace SymTouch), subcutaneous
- sutimlimab-jome (Enjaymo)
- taliglucerase alfa (Elelyso)
- tbo-filgrastim(Granix)
- teduglutide (Gattex)
- teplizumab-mzwv (Tzield)
- teprotumumab-trbw (Tepezza)
- teriparatide (Forteo)
- tesamorelin acetate (Egrifta)
- testosterone cypionate (Azmiro)
- testosterone enanthate (Xyosted)
- testosterone pellets (Testopel)
- testosterone undecanoate (Aveed)
- tezepelumab-ekko (Tezspire), prefilled pens
- tezepelumab-ekko (Tezspire), prefilled syringe and vial
- tildrakizumab-asmn (Ilumya)
- timothy grass pollen allergen extract (Grastek)
- tocilizumab (Actemra), subcutaneous
- tocilizumab (Actemra, Tofidence, Tyenne), intravenous
- tocilizumab-aazg (Tyenne), subcutaneous
- tofersen (Qalsody)
- tralokinumab-ldrm (Adbry)
- travoprost intracameral implant (iDose TR)
- treprostinil (Remodulin)
- treprostinil (Tyvaso)
- triptorelin (Triptodur)
- ublituximab-xiiy (Briumvi)
- ustekinumab (Imuldosa, Otulfi, Pyzchiva, Selarsdi, Stelara, Steqeyma, Wezlana, Yesintek), intravenous
- valoctocogene roxaparvovec-rvox (Roctavian)
- vedolizumab (Entyvio), intravenous
- vedolizumab (Entyvio), subcutaneous
- velaglucerase alfa (VPRIV)
- velmanase alfa-tycv (Lamzede)
- vestronidase alfa (Mepsevii)
- viltolarsen (Viltepso)
- von willebrand factor, recombinant (Vonvendi)
- von Willebrand factor/coagulation factor VIII complex, Human (Wilate)
- voretigene neparvovec-rzyl (Luxturna)
- vosoritide (Voxzogo)
- vutrisiran (Amvuttra)
- ziconotide (Prialt)
- zopapogene imadenovec-drba (Papzimeos)
Medication policy user guide
This brief user guide describes our medication policy, explains terms used, and includes contact info for more information
About medication policy
Find out how our medication policy, which determines if a service will be covered by a plan, is reviewed and updated.
Drug formulary, policy and forms
Search our drug formulary database, get prior authorization forms, and find information on oral and topical drugs, home-injectable drugs and more.